EUVIMEDEUVIMED entdecken
Crossref

Zinc Coordination Lipid Nanoparticles Co‐Delivering Calcium Peroxide and Chelating STING agonist for Enhanced Cancer Metalloimmunotherapy

Qian Qiu, Jiexin Li, He Ren, Jingyu Zhang, Gengqi Liu, Ruiqi Yang, Boyang Sun, Chen Zhang, Yumiao Zhang iD

Small · 2024

DOI: 10.1002/smll.202402308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2024. Verfasst von Qian Qiu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering and Technology, Key Laboratory of Systems Bioengineering (Ministry of Education), Frontiers Science Center for Synthet…. Hauptthemen laut MEDLINE: Nanoparticles, Zinc, Immunotherapy, Peroxides. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program, National Basic Research Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metalloimmunotherapy has achieved great preclinical success against malignant tumors. Nonetheless, the limited immune cell infiltration and impaired immunogenicity within the tumor microenvironment (TME) significantly hinder its translation to clinical applications. In this study, a zinc coordination lipid nanoparticle is developed loaded with calcium peroxide hydrate (CaO 2 ) nanoparticles and the STING agonist diABZI‐2, which is termed A‐CaO 2 ‐Zn‐LNP. The release of Zn 2+ from the A‐CaO 2 ‐Zn‐LNP and the calcium overload synergistically induced immunogenic cell death (ICD). In addition, CaO 2 nanoparticles can consume H + and release oxygen (O 2 ) under acidic conditions. This treatment increased the pH and alleviated the hypoxia of the TME. Along with cGAS‐STING activation by diABZI‐2, A‐CaO 2 ‐Zn‐LNP ultimately results in enhanced anti‐tumor systemic immunity and long‐term immune memory via alleviating the immunosuppressive microenvironment. Taken together, A‐CaO 2 ‐Zn‐LNP offers a new nanoplatform that expands its application for cancer treatment by metalloimmunotheray.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesZincImmunotherapyPeroxidesLipidsAnimalsMiceTumor MicroenvironmentNeoplasmsCell Line, TumorChelating AgentsHumansMembrane Proteins

Stichwörter der Autor:innen

calcium overloadimmunogenic cell deathmetalloimmunotherapyreprogrammingtumor microenvironment

Substanzen

calcium peroxideZincPeroxidesLipidsChelating AgentsMembrane Proteins

Autor:innen und Institutionen

  • School of Chemical Engineering and Technology, Key Laboratory of Systems Bioengineering (Ministry of Education), Frontiers Science Center for Synthetic Biology (Ministry of Education), Tianjin University, Tianjin, 30035…

ORCID-Profile: Yumiao Zhang

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program
  • National Basic Research Program of China

Zitieren

APA

Qiu, Q., Li, J., Ren, H., Zhang, J., Liu, G., Yang, R., Sun, B., Zhang, C., & Zhang, Y. (2024). Zinc Coordination Lipid Nanoparticles Co‐Delivering Calcium Peroxide and Chelating STING agonist for Enhanced Cancer Metalloimmunotherapy. Small. https://doi.org/10.1002/smll.202402308

Vancouver

Qiu Q, Li J, Ren H, Zhang J, Liu G, Yang R, et al. Zinc Coordination Lipid Nanoparticles Co‐Delivering Calcium Peroxide and Chelating STING agonist for Enhanced Cancer Metalloimmunotherapy. Small. 2024. doi:10.1002/smll.202402308

BibTeX
@article{Qiu2024,
  author = {Qiu, Qian and Li, Jiexin and Ren, He and Zhang, Jingyu and Liu, Gengqi and Yang, Ruiqi and Sun, Boyang and Zhang, Chen and Zhang, Yumiao},
  title = {Zinc Coordination Lipid Nanoparticles Co‐Delivering Calcium Peroxide and Chelating STING agonist for Enhanced Cancer Metalloimmunotherapy},
  journal = {Small},
  year = {2024},
  doi = {10.1002/smll.202402308}
}
Kostenlos starten →